These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 12731456

  • 1. Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.
    Ratner P, Hampel F, Gispert J.
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):111-5. PubMed ID: 12731456
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
    Storms WW.
    Drugs; 1996 Mar; 52 Suppl 1():20-5. PubMed ID: 8828022
    [Abstract] [Full Text] [Related]

  • 7. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P, Bremard-Oury C, Zeisser P.
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
    [Abstract] [Full Text] [Related]

  • 8. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May 29; 145(22):51. PubMed ID: 12866281
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M, Melac M, Charpentier JC, Didier A.
    Ann Allergy Asthma Immunol; 1998 May 29; 80(5):399-403. PubMed ID: 9609610
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
    Bousquet J, Gaudaño EM, Palma Carlos AG, Staudinger H.
    Allergy; 1999 Jun 29; 54(6):562-8. PubMed ID: 10435469
    [Abstract] [Full Text] [Related]

  • 13. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM, Serra-Batlles J, Meseguer J, Castillo JA, De Molina M, Valero A, Picado C, Rupatadine Study Group.
    Allergy; 2004 Jul 29; 59(7):766-71. PubMed ID: 15180765
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis.
    Frank H, Gillen M, Rohatagi SS, Lim J, George G, Ebastine Study Group.
    J Clin Pharmacol; 2002 Oct 29; 42(10):1097-104. PubMed ID: 12362923
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD, Angello JT, Wu MM, Druce HM.
    Ann Allergy Asthma Immunol; 2006 Apr 29; 96(4):606-14. PubMed ID: 16680933
    [Abstract] [Full Text] [Related]

  • 17. A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients.
    Ankier SI, Warrington SJ.
    J Intern Med; 1989 Dec 29; 226(6):453-8. PubMed ID: 2577377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J.
    Allergy; 2008 Dec 29; 63 Suppl 89():1-20. PubMed ID: 19032340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.